SCHEMBL6236384

SCHEMBL6236384

CCOC(=O)CC1c2cc(Cl)ccc2C(=O)N1CC(C)C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
RAB9A P51151 2/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
ATM Q13315 1/20 0.42
HTT P42858 2/20 0.41
CYP11B1 P15538 5/20 0.40
CYP11B2 P19099 5/20 0.40
PIN1 Q13526 1/20 0.40
PIN4 Q9Y237 1/20 0.40
KDM4E B2RXH2 2/20 0.39
HPGD P15428 2/20 0.39
NPSR1 Q6W5P4 2/20 0.39
NPC1 O15118 1/20 0.39
FAAH O00519 1/20 0.39
BRD4 O60885 2/20 0.37
MAPT P10636 1/20 0.37
TSHR P16473 1/20 0.37
USP2 O75604 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27568972 0.91 ALDH1A1 (0.43) ALDH1A1SMN1; SMN2RAB9AMEN1KMT2A
SCHEMBL6231541 0.89 PIN1 (0.41) ALDH1A1RAB9AMEN1KMT2AHTT
SCHEMBL6234016 0.87 TDP2 (0.42) ALDH1A1MEN1KMT2AATMPIN1
SCHEMBL4466269 0.85 MDM2 (0.45) CYP11B1CYP11B2KDM4EHPGD
SCHEMBL6233172 0.85 PIN1 (0.38) ALDH1A1SMN1; SMN2HTTCYP11B1CYP11B2
SCHEMBL27528495 0.84 CYP11B1 (0.43) ALDH1A1CYP11B1CYP11B2PIN1PIN4
SCHEMBL27528478 0.84 IDO1 (0.52) ALDH1A1SMN1; SMN2RAB9AHTTPIN1
SCHEMBL27552574 0.82 ALDH1A1 (0.44) ALDH1A1SMN1; SMN2RAB9AMEN1KMT2A
SCHEMBL13708555 0.80 HTR2B (0.40) CYP11B1CYP11B2
SCHEMBL27528482 0.80 ALDH1A1 (0.39) ALDH1A1MEN1KMT2AATMHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1290833-C N- ((3-oxo2, 3-dihydro-1H-isoindol-1-yl) acetyl) guanidine derivatives as NHE-1 inhibitors for the treatment of infarction and angina pectoris SANOFI AVENTIS PHARMA GMBH (DE) 2006-12-20 CN disclosed
EP-1528923-A1 N-((3-OXO-2,3-DIHYDRO-1H-ISOINDOL-1-YL)ACETYL)GUANIDINE DERIVATIVES AS NHE1-INHIBITORS FOR THE TREATMENT OF INFARCTION AND ANGINA PECTORIS Aventis Pharma Deutschland GmbH (DE) 2005-05-11 EP disclosed
WO-2003101450-A1 N- ((3-OXO2, 3-DIHYDRO-1H-ISOINDOL-1-YL) ACETYL) GUANIDINE DERIVATIVES AS NHE-1 INHIBITORS FOR THE TREATMENT OF INFARCTION AND ANGINA PECTORIS AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2003-12-11 WO disclosed